Recovery of serum testosterone after neoadjuvant androgen deprivation therapy and radical radiotherapy in localized prostate cancer

BJU International

Volumn 97, Issue 3, 2006, Pages 476-479

  Murthy, Vedang ^a,b   Norman, Andrew R ^a   Shahidi, Mehdi ^a   Parker, Christopher C ^a   Horwich, Alan ^a   Huddart, Robert A ^a   Bange, Arsha ^a   Dearnaley, David P ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

FSH; LH; LHRH analogue; Radiotherapy; Testosterone recovery

Indexed keywords

ANDROGEN; CYPROTERONE ACETATE; FOLLITROPIN; GONADORELIN DERIVATIVE; GOSERELIN; LUTEINIZING HORMONE; TESTOSTERONE;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CONFIDENCE INTERVAL; FOLLITROPIN BLOOD LEVEL; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; SHORT COURSE THERAPY; TESTOSTERONE BLOOD LEVEL;

AGED; ANDROGEN ANTAGONISTS; ANTINEOPLASTIC AGENTS, HORMONAL; COMBINED MODALITY THERAPY; FOLLICLE STIMULATING HORMONE; GOSERELIN; HUMANS; LEUPROLIDE; LUTEINIZING HORMONE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOADJUVANT THERAPY; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; TESTOSTERONE; TREATMENT OUTCOME;

EID: 33645001367     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2006.06013.x     Document Type: Article

References (19)

1. Pilepich MV Krall JM al-Sarraf M et al. Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the Radiation Therapy Oncology Group Urology 1995 45 616 23
2. Laverdiere J Gomez JL Cusan L et al. Beneficial effect of combination hormonal therapy administered prior and following external beam radiation therapy in localized prostate cancer Int J Radiat Oncol Biol Phys 1997 37 247 52
3. D'Amico AV Manola J Loffredo M Renshaw AA DellaCroce A Kantoff PW 6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial JAMA 2004 292 821 7
4. Leuprolide Study Group. Leuprolide versus diethylstilbestrol for metastatic prostatic cancer N Engl J Med 1984 311 1281 6
5. Soloway M Chodak G Vogelzang N et al. Zoladex versus orchiectomy in treatment of advanced prostate cancer: a randomized trial. Zoladex Prostate Study Group Urology 1991 37 46 51
6. Padula GD Zelefsky MJ Venkatraman ES et al. Normalization of serum testosterone levels in patients treated with neoadjuvant hormonal therapy and three-dimensional conformal radiotherapy for prostate cancer Int J Radiat Oncol Biol Phys 2002 52 439 43
7. Nejat RJ Rashid HH Bagiella E Katz AE Benson MC A prospective analysis of time to normalization of serum testosterone after withdrawal of androgen deprivation therapy J Urol 2000 164 1891 4
8. Shahidi M Norman AR Gadd J Huddart RA Horwich A Dearnaley DP Recovery of serum testosterone, LH and FSH levels following neoadjuvant hormone cytoreduction and radical radiotherapy in localized prostate cancer Clin Oncol (R Coll Radiol) 2001 13 291 5
9. Shearer RJ Davies JH Gelister JS Dearnaley DP Hormonal cytoreduction and radiotherapy for carcinoma of the prostate Br J Urol 1992 69 521 4
10. Oefelein MG Time to normalization of serum testosterone after 3-month luteinizing hormone-releasing hormone agonist administered in the neoadjuvant setting: implications for dosing schedule and neoadjuvant study consideration J Urol 1998 160 1685 8
11. Dearnaley DP Norman AR Shahidi M Re: Time to normalization of serum testosterone after 3-month luteinizing hormone-releasing hormone agonist administered in the neoadjuvant setting: implications for dosing schedule and neoadjuvant study consideration J Urol 1999 162 170
12. Meinhardt W Horenblas S Re: Time to normalization of serum testosterone after 3-month luteinizing hormone-releasing hormone agonist administered in the neoadjuvant setting: implications for dosing schedule and neoadjuvant study consideration J Urol 1999 162 170 1
13. Izard M Leydig cell function and radiation: a review of the literature Radiother Oncol 1995 34 1 8
14. Shapiro E Kinsella TJ Makuch RW et al. Effects of fractionated irradiation on endocrine aspects of testicular function J Clin Oncol 1985 3 1232 9
15. Hermann RM Henkel K Christiansen H et al. Testicular dose and hormonal changes after radiotherapy of rectal cancer Radiother Oncol 2005 75 83 8
16. Huhtaniemi I Nikula H Parvinen M Rannikko S Histological and functional changes of the testis tissue during GnRH agonist treatment of prostatic cancer Am J Clin Oncol 1988 11 Suppl. 1 S11 5
17. Huhtaniemi I Nikula H Rannikko S Treatment of prostatic cancer with a gonadotropin-releasing hormone agonist analog: acute and long term effects on endocrine functions of testis tissue J Clin Endocrinol Metab 1985 61 698 704
18. Lamb DS Denham JW Mameghan H et al. Acceptability of short term neo-adjuvant androgen deprivation in patients with locally advanced prostate cancer Radiother Oncol 2003 68 255 67
19. Henderson A Langley SE Laing RW Is bicalutamide equivalent to goserelin for prostate volume reduction before radiation therapy? A prospective, observational study Clin Oncol (R Coll Radiol) 2003 15 318 21